ANDA User Fees Offer Sponsor Relief, But More Facility Pain
Executive Summary
Final GDUFA I application fees decrease amid expected boost in submissions, while facility fees will increase for the fourth time in five years.
You may also be interested in...
Another ANDA Submission Surge Begins
US FDA receives more than 100 ANDAs during the first month of GDUFA year five, suggesting sponsors want the new 10-month review goal and cheaper user fee.
Another ANDA Submission Surge Begins
US FDA receives more than 100 ANDAs during the first month of GDUFA year five, suggesting sponsors want the new 10-month review goal and cheaper user fee.
ANDA Approvals, Complete Responses Hit Record In FY 2016
FDA's Office of Generic Drugs completes its best year of the GDUFA era.